COVID-19 outpatient management: Shorter time to recovery in Healthcare workers according to an electronic daily symptoms assessment

被引:1
作者
Breugnon, E. [1 ]
Thollot, H. [2 ]
Fraissenon, A. [3 ]
Saunier, F. [1 ]
Labetoulle, R. [1 ]
Pillet, S. [4 ,5 ]
Lucht, F. [1 ,5 ,6 ]
Berthelot, P. [1 ,5 ,6 ]
Botelho-Nevers, E. [1 ,5 ,6 ]
Gagneux-Brunon, A. [1 ,5 ,6 ]
机构
[1] Univ Hosp St Etienne, Dept Hyg & Infect Dis, F-42055 St Etienne 2, France
[2] Univ Hosp St Etienne, Dept Publ Hlth & Biostat, St Etienne, France
[3] Univ Hosp St Etienne, Dept Radiol, St Etienne, France
[4] Univ Hosp St Etienne, Lab Microbiol & Hyg, St Etienne, France
[5] Univ Lyon, Univ Jean Monnet, Grp Immunite Muqueuses & Agents Pathogenes, St Etienne, France
[6] Univ Hosp St Etienne, CIC INSERM 1408, St Etienne, France
来源
INFECTIOUS DISEASES NOW | 2021年 / 51卷 / 01期
关键词
Covid-19; Outpatient; Healthcare workers; Healthcare professionals; Outcomes;
D O I
10.1016/j.medmal.2020.10.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Our aim is to compare the course of the disease between healthcare workers (HCWs) and non-HCWs suffering from covid-19 and eligible for outpatient management. Methods: Single-center prospective cohort of outpatients with covid-19, diagnosed between the 10th March and the 2nd April, 2020 with a daily collection of symptoms by an on-line auto-questionnaire. Results: A total of 186 patients were included (median age, 41 years [interquartile range, 19-78 years]; 74.2% female), of whom 132 (71%) were HCWs. The median follow-up after symptom onset was 14 (min 4-max 24) days. HCWs were significantly younger than non-HCWs (median age 40.3 years vs. 47.2 years [P<0.005]), and 81.8% were women. Four patients (2.2%) were hospitalized including one HCW. The median time to recovery was 9 days after symptom onset (95% CI 8-11) in the global population and respectively 8 (95% CI 8-9) and 13 (95% CI 11-15) days in HCWs and in non-HCWs (P<0.005). After adjusting for age, co-morbidities, and gender, the instantaneous risk ratio for symptom absence in HCWs was 1.76 compared with non-HCWs (95% CI [1.16-2.67], P=0.037). Conclusion: HCWs suffering from covid-19 had favorable outcomes and had a shorter time to recovery than non HCWs. (C) 2020 Published by Elsevier Masson SAS.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 18 条
[1]   Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study [J].
Bi, Qifang ;
Wu, Yongsheng ;
Mei, Shujiang ;
Ye, Chenfei ;
Zou, Xuan ;
Zhang, Zhen ;
Liu, Xiaojian ;
Wei, Lan ;
Truelove, Shaun A. ;
Zhang, Tong ;
Gao, Wei ;
Cheng, Cong ;
Tang, Xiujuan ;
Wu, Xiaoliang ;
Wu, Yu ;
Sun, Binbin ;
Huang, Suli ;
Sun, Yu ;
Zhang, Juncen ;
Ma, Ting ;
Lessler, Justin ;
Feng, Tiejian .
LANCET INFECTIOUS DISEASES, 2020, 20 (08) :911-919
[2]   2019-nCoV epidemic: address mental health care to empower society [J].
Bao, Yanping ;
Sun, Yankun ;
Meng, Shiqiu ;
Shi, Jie ;
Lu, Lin .
LANCET, 2020, 395 (10224) :E37-E38
[3]  
CDC COVID-19 Response Team, 2020, MMWR Morb Mortal Wkly Rep, V69, P477, DOI 10.15585/mmwr.mm6915e6
[4]   MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018 [J].
Elkholy, Amgad A. ;
Grant, Rebecca ;
Assiri, Abdullah ;
Elhakim, Mohamed ;
Malik, Mamunur R. ;
Van Kerkhove, Maria D. .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (03) :418-422
[5]   Mild or Moderate Covid-19 [J].
Gandhi, Rajesh T. ;
Lynch, John B. ;
del Rio, Carlos .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18) :1757-1766
[6]   Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study [J].
Gautret, Philippe ;
Lagier, Jean-Christophe ;
Parola, Philippe ;
Van Thuan Hoang ;
Meddeb, Line ;
Sevestre, Jacques ;
Mailhe, Morgane ;
Doudier, Barbara ;
Aubry, Camille ;
Amrane, Sophie ;
Seng, Piseth ;
Hocquart, Marie ;
Eldin, Carole ;
Finance, Julie ;
Vieira, Vera Esteves ;
Tissot-Dupont, Herve Tissot ;
Honore, Stephane ;
Stein, Andreas ;
Million, Matthieu ;
Colson, Philippe ;
La Scola, Bernard ;
Veit, Veronique ;
Jacquier, Alexis ;
Deharo, Jean-Claude ;
Drancourt, Michel ;
Fournier, Pierre Edouard ;
Rolain, Jean-Marc ;
Brouqui, Philippe ;
Raoult, Didier .
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 34
[7]   Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure [J].
Giamarellos-Bourboulis, Evangelos J. ;
Netea, Mihai G. ;
Rovina, Nikoletta ;
Akinosoglou, Karolina ;
Antoniadou, Anastasia ;
Antonakos, Nikolaos ;
Damoraki, Georgia ;
Gkavogianni, Theologia ;
Adami, Maria-Evangelia ;
Katsaounou, Paraskevi ;
Ntaganou, Maria ;
Kyriakopoulou, Magdalini ;
Dimopoulos, George ;
Koutsodimitropoulos, Ioannis ;
Velissaris, Dimitrios ;
Koufargyris, Panagiotis ;
Karageorgos, Athanassios ;
Katrini, Konstantina ;
Lekakis, Vasileios ;
Lupse, Mihaela ;
Kotsaki, Antigone ;
Renieris, George ;
Theodoulou, Danai ;
Panou, Vassiliki ;
Koukaki, Evangelia ;
Koulouris, Nikolaos ;
Gogos, Charalambos ;
Koutsoukou, Antonia .
CELL HOST & MICROBE, 2020, 27 (06) :992-+
[8]   Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals [J].
Grifoni, Alba ;
Weiskopf, Daniela ;
Ramirez, Sydney, I ;
Mateus, Jose ;
Dan, Jennifer M. ;
Moderbacher, Carolyn Rydyznski ;
Rawlings, Stephen A. ;
Sutherland, Aaron ;
Premkumar, Lakshmanane ;
Jadi, Ramesh S. ;
Marrama, Daniel ;
de Silva, Aravinda M. ;
Frazier, April ;
Carlin, Aaron F. ;
Greenbaum, Jason A. ;
Peters, Bjoern ;
Krammer, Florian ;
Smith, Davey M. ;
Crotty, Shane ;
Sette, Alessandro .
CELL, 2020, 181 (07) :1489-+
[9]  
Haut Conseil de Sante Publique (HCSP), 2020, COR SARS COV 2 PRIS
[10]  
HCSP, 2020, AV PROV PAT RISQ FOR